Kucukgergin C - Search Results

1

Increased risk of advanced prostate cancer associated with MnSOD Ala-9-Val gene polymorphism.

Kucukgergin C, Sanli O, Tefik T, Aydın M, Ozcan F, Seckin S. Kucukgergin C, et al. Mol Biol Rep. 2012 Jan;39(1):193-8. doi: 10.1007/s11033-011-0725-2. Epub 2011 May 8. Mol Biol Rep. 2012. PMID: 21553226

2

Despite the lack of association between different genotypes and the presence of prostate cancer, endothelial nitric oxide synthase a/b (eNOS4a/b) polymorphism may be associated with advanced clinical stage and bone metastasis.

Sanli O, Kucukgergin C, Gokpinar M, Tefik T, Nane I, Seckin S. Sanli O, et al. Among authors: kucukgergin c. Urol Oncol. 2011 Mar-Apr;29(2):183-8. doi: 10.1016/j.urolonc.2009.04.011. Epub 2009 Jul 3. Urol Oncol. 2011. PMID: 19576798

3

Genetic variants of MnSOD and GPX1 and susceptibility to bladder cancer in a Turkish population.

Kucukgergin C, Sanli O, Amasyalı AS, Tefik T, Seckin S. Kucukgergin C, et al. Med Oncol. 2012 Sep;29(3):1928-34. doi: 10.1007/s12032-011-0057-z. Epub 2011 Sep 9. Med Oncol. 2012. PMID: 21904836

4

Association between genetic variants in glutathione peroxidase 1 (GPx1) gene, GPx activity and the risk of prostate cancer.

Kucukgergin C, Gokpinar M, Sanli O, Tefik T, Oktar T, Seckin S. Kucukgergin C, et al. Minerva Urol Nefrol. 2011 Sep;63(3):183-90. Minerva Urol Nefrol. 2011. PMID: 21993316

5

Association of polymorphisms in MCP-1, CCR2, and CCR5 genes with the risk and clinicopathological characteristics of prostate cancer.

Kucukgergin C, Isman FK, Cakmakoglu B, Sanli O, Seckin S. Kucukgergin C, et al. DNA Cell Biol. 2012 Aug;31(8):1418-24. doi: 10.1089/dna.2012.1716. Epub 2012 May 21. DNA Cell Biol. 2012. PMID: 22612293

6

The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.

Kucukgergin C, Isman FK, Dasdemir S, Cakmakoglu B, Sanli O, Gokkusu C, Seckin S. Kucukgergin C, et al. Gene. 2012 Dec 10;511(1):7-11. doi: 10.1016/j.gene.2012.09.011. Epub 2012 Sep 14. Gene. 2012. PMID: 22982413

7

Association between SDF1-3'A or CXCR4 gene polymorphisms with predisposition to and clinicopathological characteristics of prostate cancer with or without metastases.

Işman FK, Kucukgergin C, Daşdemir S, Cakmakoglu B, Sanli O, Seckin S. Işman FK, et al. Among authors: kucukgergin c. Mol Biol Rep. 2012 Dec;39(12):11073-9. doi: 10.1007/s11033-012-2010-4. Epub 2012 Oct 11. Mol Biol Rep. 2012. PMID: 23053994

8

Nitric oxide synthase (eNOS4a/b) gene polymorphism is associated with tumor recurrence and progression in superficial bladder cancer cases.

Amasyali AS, Kucukgergin C, Erdem S, Sanli O, Seckin S, Nane I. Amasyali AS, et al. Among authors: kucukgergin c. J Urol. 2012 Dec;188(6):2398-403. doi: 10.1016/j.juro.2012.07.096. Epub 2012 Oct 22. J Urol. 2012. PMID: 23088972

9

Manganese superoxide dismutase Ile58Thr, catalase C-262T and myeloperoxidase G-463A gene polymorphisms in patients with prostate cancer: relation to advanced and metastatic disease.

Tefik T, Kucukgergin C, Sanli O, Oktar T, Seckin S, Ozsoy C. Tefik T, et al. Among authors: kucukgergin c. BJU Int. 2013 Aug;112(4):E406-14. doi: 10.1111/bju.12176. Epub 2013 Jun 14. BJU Int. 2013. PMID: 23773345

10

The roles of serum and urinary carbohydrate antigen 19-9 in the management of patients with antenatal hydronephrosis.

Atar A, Oktar T, Kucukgergin C, Kalelioglu I, Seckin S, Ander H, Ziylan O, Kadioglu TC. Atar A, et al. Among authors: kucukgergin c. J Pediatr Urol. 2015 Jun;11(3):133.e1-5. doi: 10.1016/j.jpurol.2014.12.012. Epub 2015 Mar 13. J Pediatr Urol. 2015. PMID: 25824879

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page